Compare with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES ABBOTT INDIA ALKEM LABORATORIES/
ABBOTT INDIA
 
P/E (TTM) x - 47.0 - View Chart
P/BV x 6.7 13.5 49.7% View Chart
Dividend Yield % 0.6 0.5 126.3%  

Financials

 ALKEM LABORATORIES   ABBOTT INDIA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
ABBOTT INDIA
Mar-18
ALKEM LABORATORIES/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,5896,110 26.0%   
Low Rs1,2323,996 30.8%   
Sales per share (Unadj.) Rs417.51,552.2 26.9%  
Earnings per share (Unadj.) Rs56.3188.8 29.8%  
Cash flow per share (Unadj.) Rs64.7196.4 32.9%  
Dividends per share (Unadj.) Rs12.7055.00 23.1%  
Dividend yield (eoy) %0.91.1 82.7%  
Book value per share (Unadj.) Rs292.9796.6 36.8%  
Shares outstanding (eoy) m119.5721.25 562.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.3 103.8%   
Avg P/E ratio x25.126.8 93.6%  
P/CF ratio (eoy) x21.825.7 84.7%  
Price / Book Value ratio x4.86.3 75.9%  
Dividend payout %22.629.1 77.4%   
Avg Mkt Cap Rs m168,653107,376 157.1%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m9,1713,937 233.0%   
Avg. sales/employee Rs ThNM9,929.3-  
Avg. wages/employee Rs ThNM1,185.1-  
Avg. net profit/employee Rs ThNM1,207.7-  
INCOME DATA
Net Sales Rs m49,91532,985 151.3%  
Other income Rs m1,6451,170 140.6%   
Total revenues Rs m51,56134,155 151.0%   
Gross profit Rs m8,4825,245 161.7%  
Depreciation Rs m1,006162 621.2%   
Interest Rs m67138 1,755.5%   
Profit before tax Rs m8,4516,215 136.0%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6062,203 72.9%   
Profit after tax Rs m6,7314,012 167.8%  
Gross profit margin %17.015.9 106.9%  
Effective tax rate %19.035.4 53.6%   
Net profit margin %13.512.2 110.9%  
BALANCE SHEET DATA
Current assets Rs m27,06222,655 119.5%   
Current liabilities Rs m15,3246,681 229.4%   
Net working cap to sales %23.548.4 48.6%  
Current ratio x1.83.4 52.1%  
Inventory Days Days6765 102.7%  
Debtors Days Days4129 141.6%  
Net fixed assets Rs m12,610835 1,509.3%   
Share capital Rs m239213 112.5%   
"Free" reserves Rs m34,49016,715 206.3%   
Net worth Rs m35,02716,928 206.9%   
Long term debt Rs m1,2120-   
Total assets Rs m54,38724,162 225.1%  
Interest coverage x13.6163.7 8.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.4 67.2%   
Return on assets %13.616.8 81.2%  
Return on equity %19.223.7 81.1%  
Return on capital %24.936.9 67.3%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,563369 1,780.9%   
Fx outflow Rs m3,0123,807 79.1%   
Net fx Rs m3,552-3,438 -103.3%   
CASH FLOW
From Operations Rs m7,2591,527 475.3%  
From Investments Rs m1,864-2,148 -86.8%  
From Financial Activity Rs m-9,273-1,024 905.3%  
Net Cashflow Rs m-150-1,646 9.1%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 33.1 7.9 419.0%  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 17.1 -  
Shareholders   68,381 18,270 374.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  ELDER PHARMA  SUVEN LIFESCIENCES  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Oct 18, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS